Thank you for requesting Evolving US Biosimilars Landscape - A Medical Affairs Perspective.

To download a copy of this document, please provide the following basic information:

Leave this field empty
    It's OK to send me occasional emails with new
perspectives from inVentiv Health Consulting

Manufacturers have started to realize that biosimilars require not only a unique development pathway but also a more tailored go-to-market approach. While much has been said about the need to modify the Commercial support required for biosimilars, the role of Medical Affairs and how it needs to evolve to guide biosimilar product development strategy is yet to be defined. Similarly, the role of Medical Affairs in shaping defense strategies in the face of biosimilar competition has not been explored. inVentiv Health Consulting has leveraged its subject matter expertise in Medical Affairs as well as its experience in the biosimilar space to develop a perspective on the evolution of Medical Affairs in the era of biosimilars. The perspective is captured in this position paper and will be further validated via industry benchmarking research with key industry thought leaders.
inVentiv Health Consulting offers world class healthcare consulting services.